Surmodics Inc.

NASDAQ: SRDX · Real-Time Price · USD
29.58
-0.41 (-1.37%)
At close: Jun 05, 2025, 3:59 PM
29.80
0.74%
After-hours: Jun 05, 2025, 04:04 PM EDT

Surmodics Statistics

Share Statistics

Surmodics has 14.3M shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding 14.3M
Shares Change (YoY) 0.24%
Shares Change (QoQ) 0.01%
Owned by Institutions (%) 84.13%
Shares Floating n/a
Failed to Deliver (FTD) Shares 68
FTD / Avg. Volume 0.06%

Short Selling Information

The latest short interest is 426.71K, so 2.98% of the outstanding shares have been sold short.

Short Interest 426.71K
Short % of Shares Out 2.98%
Short % of Float 3.1%
Short Ratio (days to cover) 7.79

Valuation Ratios

The PE ratio is -47.55 and the forward PE ratio is -114.69. Surmodics's PEG ratio is -0.07.

PE Ratio -47.55
Forward PE -114.69
PS Ratio 4.35
Forward PS 3.3
PB Ratio 4.62
P/FCF Ratio -169.19
PEG Ratio -0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Surmodics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.28.

Current Ratio 3.96
Quick Ratio 3.22
Debt / Equity 0.28
Debt / EBITDA 7.03
Debt / FCF -10.25
Interest Coverage -1.59

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $324,107.97
Profits Per Employee $-29,670.95
Employee Count 389
Asset Turnover 0.71
Inventory Turnover 2.18

Taxes

Income Tax 4.04M
Effective Tax Rate -53.77%

Stock Price Statistics

The stock price has increased by -29.27% in the last 52 weeks. The beta is 1.32, so Surmodics's price volatility has been higher than the market average.

Beta 1.32
52-Week Price Change -29.27%
50-Day Moving Average 28.87
200-Day Moving Average 35.1
Relative Strength Index (RSI) 59.77
Average Volume (20 Days) 106,552

Income Statement

In the last 12 months, Surmodics had revenue of 126.08M and earned -11.54M in profits. Earnings per share was -0.82.

Revenue 126.08M
Gross Profit 93.05M
Operating Income -5.64M
Net Income -11.54M
EBITDA 4.73M
EBIT -3.97M
Earnings Per Share (EPS) -0.82
Full Income Statement

Balance Sheet

The company has 36.12M in cash and 33.24M in debt, giving a net cash position of 2.87M.

Cash & Cash Equivalents 36.12M
Total Debt 33.24M
Net Cash 2.87M
Retained Earnings n/a
Total Assets 163.21M
Working Capital 57.8M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 248K and capital expenditures -3.49M, giving a free cash flow of -3.24M.

Operating Cash Flow 248K
Capital Expenditures -3.49M
Free Cash Flow -3.24M
FCF Per Share -0.23
Full Cash Flow Statement

Margins

Gross margin is 73.81%, with operating and profit margins of -4.48% and -9.15%.

Gross Margin 73.81%
Operating Margin -4.48%
Pretax Margin -5.95%
Profit Margin -9.15%
EBITDA Margin 3.75%
EBIT Margin -4.48%
FCF Margin -2.57%

Dividends & Yields

SRDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SRDX is $43, which is 44.8% higher than the current price. The consensus rating is "Hold".

Price Target $43
Price Target Difference 44.8%
Analyst Consensus Hold
Analyst Count 2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on Dec 7, 2000. It was a forward split with a ratio of 2:1.

Last Split Date Dec 7, 2000
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 6.25
Piotroski F-Score 3